Stay updated on Oral vs Injectable for First-Episode Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the Oral vs Injectable for First-Episode Schizophrenia Clinical Trial page.

Latest updates to the Oral vs Injectable for First-Episode Schizophrenia Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has updated its version from v2.15.0 to v2.15.2.SummaryDifference0.3%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference6%
- Check95 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
Stay in the know with updates to Oral vs Injectable for First-Episode Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral vs Injectable for First-Episode Schizophrenia Clinical Trial page.